FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene. [electronic resource]
Producer: 20150904Description: 3884-95 p. digitalISSN:- 1557-3265
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- metabolism
- Cell Line, Tumor
- Chemoradiotherapy
- Fanconi Anemia Complementation Group D2 Protein -- physiology
- Female
- Humans
- Mice, SCID
- Morpholines -- pharmacology
- Oncogene Proteins, Fusion -- metabolism
- Paired Box Transcription Factors -- metabolism
- Radiation Tolerance
- Rhabdomyosarcoma, Alveolar -- drug therapy
- Signal Transduction
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.